# PHR earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/PHR) · [Earnings tab](https://www.lopjlb.com/stock/PHR?tab=earnings) Updated: 2026-09-02T06:40:02 Quarters analyzed: 8 ## Cross-quarter narrative From Q2 FY2025 through Q1 FY2027 Phreesia moved from establishing positive cash flow and early product rollouts toward a more mature growth engine anchored by AI‑enabled solutions and a strategic AccessOne acquisition. Revenue rose each quarter, prompting raised guidance in FY2025‑26, but FY2027 revenue guidance was later trimmed as visibility into pharma spend and Network Solutions demand waned. Margins improved markedly, with adjusted EBITDA margins climbing from roughly 15% in Q4 FY2025 to 23% in Q1 FY2027, driven by higher‑margin Network Solutions mix and AI‑driven efficiency. The company repeatedly highlighted integration risk—first with MEDITECH and Oracle, later with AccessOne—while also noting recurring concerns around sales‑and‑marketing spend leverage, regulatory uncertainty, and competitive pressure from large platform vendors. Natural‑disaster and election‑year impacts surfaced early but faded from later calls. Capital strategy shifted from free‑cash‑flow‑funded organic investment to a blend of bridge‑loan financing and credit‑facility refinancings to support AccessOne and AI initiatives. Overall the narrative reflects a transition from early‑stage rollout execution to scaling AI products and acquisition integration amid evolving macro and competitive headwinds. ## Latest CallCard · Q1 Phreesia posted Q1 FY2027 revenue of $130.9M (+13% YoY) driven by 40% growth in Payment Solutions, highlighted Access One financing expansion, AI initiatives and maintained FY2027 guidance. **Guidance:** maintained — Revenue outlook unchanged at $510M-$520M and adjusted EBITDA $125M-$135M for FY2027. **Tone:** mgmt 0.6 · Q&A pressure 0.4 · divergence 0.2 Prepared remarks emphasized foundational work, AI opportunities and a positive outlook, signaling optimism. ### Demand visibility Moderate visibility with consistent outlook for most segments. Visibility generally consistent with March 2026 view, but network solutions revenue shows more variability in the second half due to lower client spend and regulatory factors. ### Margins / costs EBITDA margin stable at 23% with focus on operating leverage. Restructuring plan and AI adoption aim to reduce manual costs and improve margin; adjusted EBITDA outlook unchanged. ### Capital allocation Refinanced bridge loan and expanded credit facilities to fund growth. Completed $275M revolving credit with Capital One, $84M borrowings outstanding, and expanded Access One securitization to $300M for financing solutions. ### Milestones - **Access One acquisition** [delivered]: Closed in Q4 FY2026, now integrated into financing solutions. - **Bridge loan refinancing** [delivered]: Replaced bridge loan with $275M Capital One revolving facility on March 13. - **Access One securitization expansion** [delivered]: Facility increased to $300M through April 2029 with PNC Bank. - **Restructuring plan implementation** [new]: May 2026 plan to reduce operating expenses, expected annualized savings baked into outlook. - **AI initiatives** [on_track]: Targeting cost reductions and revenue growth through AI across the business. - **Provider Connect product launch** [on_track]: New provider product launched earlier fiscal year, built from zero in FY20, contributing to guidance. - **Axis 1 integration into pay network** [on_track]: Integrating Axis 1 to enhance pay network flow. - **Access One financing solution rollout** [on_track]: Expanding financing to non‑investment‑grade clients to improve cash flow. ### Fears / risks - **Network Solutions revenue pressure**: Clients committing lower spend levels due to brand dynamics and regulatory policies. - **Forecast variability**: Increased variability in internal network solutions revenue forecasting, especially H2. - **Access One integration risk**: Early stage integration and uncertain economics of expanded financing to new provider types. - **Subscription revenue moderation**: Shift to better, faster, cheaper pricing may affect subscription dollar per client and retention. - **Macro demand risk**: Higher patient out‑of‑pocket costs could impact Payment Solutions demand. - **Regulatory risk**: Regulatory policies affecting client spend could dampen revenue growth. - **Technology execution risk**: Reliance on AI to deliver operating leverage carries implementation risk. - **Credit risk with non‑investment‑grade clients**: Financing non‑investment‑grade providers may increase credit exposure. ### Key quotes > “We've done serious foundational work over the last few years. on our infrastructure, our security, our operational discipline, and it's paying off.” > “Revenue was $130.9 million, up 13% year-over-year. Year-over-year growth was led by Payment Solutions at 40% and followed by Network Solutions at 15%.” > “The savings generated are baked into our outlook for the year, we're not going to break out a specific contribution from that, but it's something we planned for.” — Balaji Gandhi ## Quarter one-liners - **2027 Q1:** Phreesia posted Q1 FY2027 revenue of $130.9M (+13% YoY) driven by 40% growth in Payment Solutions, highlighted Access One financing expansion, AI initiatives and maintained FY2027 guidance. - **2026 Q4:** Phreesia posted record Adjusted EBITDA, first‑time GAAP profit and strong cash flow, but lowered FY2027 revenue guidance due to reduced visibility in Network Solutions while keeping EBITDA outlook unchanged and highlighting AccessOne scaling, ProviderConnect launch, and AI‑driven margin expansion. - **2026 Q3:** — - **2026 Q2:** Phreesia Q2 FY2026 delivered its first positive net income, announced a $160M AccessOne acquisition, launched Voice AI, and maintained FY2026 revenue guidance while raising EBITDA outlook. - **2026 Q1:** — - **2025 Q4:** Phreesia Q4 FY25: revenue $109.7M (+15% YoY), adj. EBITDA $16.4M (+$19.9M YoY), 3rd straight quarter positive FCF; FY26 guidance $400-482M revenue, $78-88M EBITDA maintained; Network Solutions strength, AI adoption, patient bill pay rollout, no FY25 acquisitions. - **2025 Q3:** Phreesia Q3 FY2025 revenue rose 17% to $106.8M, posted positive cash flow, raised FY2025 adjusted EBITDA outlook and gave a bullish FY2026 outlook while noting hurricane impacts and ongoing acquisition integration. - **2025 Q2:** Phreesia posted Q2 FY2025 revenue of $102.1M, hit positive operating and free cash flow, raised FY2025 EBITDA guidance and reaffirmed revenue outlook while highlighting product rollouts and integration plans. ## Theme arcs - **Revenue growth** (improving): Quarterly revenue rose 15‑17% YoY and guidance was raised before being trimmed for FY2027 due to visibility concerns - **Margin expansion** (improving): Adjusted EBITDA margin grew from 15% to 23% as higher‑margin Network Solutions and AI efficiency took hold - **Product rollout** (new): Patient Bill Pay, Voice AI, ProviderConnect and AI forecasting launched across the period - **Acquisition strategy** (improving): AccessOne announced and progressed, adding financing capabilities - **Integration risk** (deteriorating): Ongoing phased integrations (MEDITECH, Oracle, AccessOne) remain at risk - **Competitive pressure** (deteriorating): Large platform vendors entered AI scheduling and verification space - **Macro/policy visibility** (deteriorating): Reduced visibility into pharma spend and Medicaid/Medicare changes impacted guidance - **AI adoption** (improving): AI drives margin expansion and new product capabilities ## Fear persistence - **Revenue growth/visibility** [recurring]: Repeated concerns about sustaining growth and pharma spend visibility ## Guidance path 2025 Q2:raised → 2025 Q3:raised → 2025 Q4:maintained → 2026 Q1:vague → 2026 Q2:maintained → 2026 Q3:vague → 2026 Q4:lowered → 2027 Q1:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/PHR`